多重检测市场 - 按产品(耗材、仪器、软件和服务)、检测类型、技术和地理划分 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

多重检测市场按类型、技术、最终用户(制药和生物制药公司、合同研究组织、其他)和地理划分。

市场快照

multiplex assays market size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 4.2 %
multiplex assays market major players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

由于慢性病患病率的上升、个性化医疗的日益普及以及多重检测相对于传统检测的广泛优势,多重检测市场将显示出快速增长。

个性化医疗旨在根据疾病的分子基础为个体患者提供量身定制的治疗,这在近年来变得流行。伴随诊断正在成为个性化医疗不可或缺的一部分,并且无论在数量上还是在疾病领域的应用上都在迅速扩大。按照目前的产品线,在可预见的未来,伴随诊断的快速增长是可能的。伴随诊断的这种扩展也有望对全球多重检测市场的发展产生重大影响。促进市场增长的其他因素包括多路复用技术的优势,例如增加的吞吐量。 

然而,高昂的采购和运营成本以及多重分析仪器的繁琐和复杂性仍然是一个重大障碍,可能会阻碍预测期内的市场增长。

Scope of the report

Multiplex assays enable the detection of multiple analytes in a single cycle of the test. Multiplex assays are being utilized in different fields of life science, such as in functional genomics to detect the different types of biomolecules, such as proteins, and DNA simultaneously. In comparison to conventional assays, the multiplex techniques require a small amount of analytes and enable significant savings in costs and lab time.

By Type
Cell-Based Multiplex Assays
Protein Multiplex Assays
Nucleic Acid Multiplex Assays
By Technology
Multiplex Real-Time PCR
Flow Cytometry
Other Technologies
End-User
Pharmaceutical and Biopharmaceutical Companies
Contract Research Organizations
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-Eastst and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

制药和生物技术公司部门预计将在多重检测市场中占据主要市场份额

  • 制药和生物技术公司部门在多重检测市场中占有重要的市场份额,并且由于在制造和药物开发和发现过程中的利用率不断提高,预计在预测期内将显示出类似的趋势。
  • 根据美国制药研究与制造商协会和英国制药工业协会的出版物估计,全球制药研发支出已从 2006 年的 1081 亿美元增长到 2016 年的 1567 亿美元,这反过来又增加了导致多重检测市场的增长。
  • 越来越多地采用用于诊断癌症、免疫系统疾病、骨髓疾病和其他传染病的多重检测以及多重检测技术的技术进步也在推动市场。
multiplex assays market trends

北美市场份额最大,有望保持主导地位

  • 就收入而言,北美是最大的区域市场。癌症等慢性病的日益流行、人口老龄化、对靶向和个性化医疗的需求不断增长以及政府的积极举措是巨大市场规模背后的主要因素。这种增长还可以归因于先进的诊断实验室的存在和新型检测技术的高接受率。
  • 预计亚太地区将在预测期内录得市场上最高的复合年增长率。亚太地区的增长主要受到政府不断增加的研发投资和该地区基础设施发展的推动。
multiplex assays market share

竞争格局

在全球多重检测市场上运营的主要参与者是 Thermo Fisher Scientific, Inc.、Abcam、Merck KGaA、Perkinelmer, Inc.、Bio-Rad Laboratories, Inc. 和 Promega Corporation。产品创新和为开发先进技术而进行的持续研发活动有助于促进市场的增长。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Adoption of Personalized-Precision Medicine

      2. 4.2.2 Increasing Burden of Chronic Diseases

      3. 4.2.3 Distinct Advantages of Multiplex Assays over singleplex assays

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Equipment Coupled with Cumbersome and Complexity of the Procedure

      2. 4.3.2 Regulatory Constraints

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type

      1. 5.1.1 Cell-Based Multiplex Assays

      2. 5.1.2 Protein Multiplex Assays

      3. 5.1.3 Nucleic Acid Multiplex Assays

    2. 5.2 By Technology

      1. 5.2.1 Multiplex Real-Time PCR

      2. 5.2.2 Flow Cytometry

      3. 5.2.3 Other Technologies

    3. 5.3 End-User

      1. 5.3.1 Pharmaceutical and Biopharmaceutical Companies

      2. 5.3.2 Contract Research Organizations

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-Eastst and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abcam plc.

      2. 6.1.2 Bio-Rad Laboratories, Inc.

      3. 6.1.3 Biomerieux SA

      4. 6.1.4 Hologic Corporation

      5. 6.1.5 Luminex Corporation

      6. 6.1.6 Merck KGaA

      7. 6.1.7 Perkin Elmer Inc.

      8. 6.1.8 Promega Corporation

      9. 6.1.9 Quansys Biosciences Inc.

      10. 6.1.10 Seegene Inc.

      11. 6.1.11 Thermo Fisher Scientific

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Multiplex Assays Market market is studied from 2018 - 2026.

The Multiplex Assays Market is growing at a CAGR of 4.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Bio-Rad Laboratories, Inc., Merck KGaA, Quansys Biosciences Inc., Thermo Fisher Scientific, Abcam plc. are the major companies operating in Multiplex Assays Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!